Medtronic 2014 Annual Report Download - page 4

Download and view the complete annual report

Please find page 4 of the 2014 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 147

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147

While the transaction continues to make us more of a global company, it also gives us the capacity to both return additional
capital to our shareholders and to invest much more aggressively in U.S. innovation to drive long-term growth. In fact, we are
committed to investing an incremental $10 billion in U.S. technology over the next decade, which will result in global growth
and increased U.S. exports. This helps preserve U.S. global leadership in medical technology innovation, and ultimately will
lead to better healthcare systems in the U.S. and around the world.
We are extremely excited about this acquisition, and believe that the combination of Covidien with Medtronic gives us an even
better platform to deliver reliable performance and generate sustainable, long-term value for our shareholders.
There remains significant opportunity in healthcare. People’s desire to live longer, healthier, more productive and pain free lives
will always exist. This is not going to stop in 2015 – there will always be a need for what we do.
We have made tremendous progress as a company and healthcare community around the globe. Yet, we have so much more to
do. We can make our therapies and services more valuable and integral to healthcare; we can treat more people in more ways;
and we can do this in ways that the individual and the system can afford. These are the objectives we seek to address, and I
could not be more excited about the role that Medtronic can play in making this a reality.
Thank you for your ownership of and trust in our company as we continue on our journey to pursue our Mission – to alleviate
pain, restore health, and extend life for patients around the world.
Omar Ishrak
Chairman and Chief Executive Officer